pyrroles has been researched along with gdc 0449 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saif, MW; Sarris, EG; Syrigos, KN | 1 |
| Ishii, T; Kondo, S; Matsui, H; Nakashima, K; Ogawa, K; Sasaki, S; Shimizu, Y | 1 |
| Ishii, T; Matsui, H; Nakayama, M; Ogawa, K; Sasaki, S; Shimizu, Y | 1 |
3 other study(ies) available for pyrroles and gdc 0449
| Article | Year |
|---|---|
Novel agents and future prospects in the treatment of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Indoles; Niacinamide; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sunitinib; Treatment Outcome | 2013 |
Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant.
Topics: Anilides; Animals; Antineoplastic Agents; Drug Resistance, Neoplasm; Drugs, Investigational; Hedgehog Proteins; HEK293 Cells; Humans; Mice; Mutation; NIH 3T3 Cells; Pyridines; Pyrroles; Receptors, G-Protein-Coupled; Smoothened Receptor | 2014 |
Biochemical characterization of smoothened receptor antagonists by binding kinetics against drug-resistant mutant.
Topics: Anilides; Binding, Competitive; Cell Line; Drug Resistance, Neoplasm; Humans; Kinetics; Mutation; Pyridines; Pyrroles; Radioligand Assay; Receptors, G-Protein-Coupled; Smoothened Receptor; Veratrum Alkaloids | 2015 |